Ceredex Value Advisors LLC Acquires New Position in Regeneron Pharmaceuticals, Inc. $REGN
Ceredex Value Advisors LLC has acquired a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) during the second quarter, purchasing 69,370 shares valued at approximately $43.255 million. This investment now represents 1.2% of Ceredex Value Advisors LLC's portfolio, making it their 14th largest holding. Other …